| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |